Home/Filings/4/0000950170-23-052933
4//SEC Filing

Adams Laura Lee 4

Accession 0000950170-23-052933

CIK 0001492674other

Filed

Oct 10, 8:00 PM ET

Accepted

Oct 11, 5:00 PM ET

Size

6.6 KB

Accession

0000950170-23-052933

Insider Transaction Report

Form 4
Period: 2023-09-15
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-152,3000 total
    Common Stock (2,300 underlying)
  • Exercise/Conversion

    Common Stock

    2023-09-15+2,3003,032 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On October 11, 2022, the reporting person was granted 2,300 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.

Documents

1 file

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001891764

Filing Metadata

Form type
4
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 5:00 PM ET
Size
6.6 KB